HomeCompareNVIV vs NNN

NVIV vs NNN: Dividend Comparison 2026

NVIV yields 623.64% · NNN yields 5.68%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 NVIV wins by $353147.43M in total portfolio value
10 years
NVIV
NVIV
● Live price
623.64%
Share price
$0.32
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$353147.46M
Annual income
$268,464,858,212.91
Full NVIV calculator →
NNN
NNN REIT Inc.
● Live price
5.68%
Share price
$41.89
Annual div
$2.38
5Y div CAGR
8.6%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$25.6K
Annual income
$2,637.42
Full NNN calculator →

Portfolio growth — NVIV vs NNN

📍 NVIV pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodNVIVNNN
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, NVIV + NNN cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
NVIV pays
NNN pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

NVIV
Annual income on $10K today (after 15% tax)
$53,009.04/yr
After 10yr DRIP, annual income (after tax)
$228,195,129,480.97/yr
NNN
Annual income on $10K today (after 15% tax)
$482.93/yr
After 10yr DRIP, annual income (after tax)
$2,241.81/yr
At 15% tax rate, NVIV beats the other by $228,195,127,239.17/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of NVIV + NNN for your $10,000?

NVIV: 50%NNN: 50%
100% NNN50/50100% NVIV
Portfolio after 10yr
$176573.74M
Annual income
$134,232,430,425.17/yr
Blended yield
76.02%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on NNN right now

NVIV
Analyst Ratings
3
Buy
Consensus: Buy
Altman Z
-38.6
Piotroski
2/9
NNN
Analyst Ratings
10
Buy
15
Hold
4
Sell
Consensus: Hold
Price Target
$44.93
+7.3% upside vs current
Range: $43.00 — $48.50
Altman Z
1.1
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

NVIV buys
0
NNN buys
0
No recent congressional trades found for NVIV or NNN in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricNVIVNNN
Forward yield623.64%5.68%
Annual dividend / share$2.00$2.38
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%8.6%
Portfolio after 10y$353147.46M$25.6K
Annual income after 10y$268,464,858,212.91$2,637.42
Total dividends collected$346135.20M$13.7K
Payment frequencyquarterlyquarterly
SectorStockREIT
Analyst consensusBuyHold

Year-by-year: NVIV vs NNN ($10,000, DRIP)

YearNVIV PortfolioNVIV Income/yrNNN PortfolioNNN Income/yrGap
1← crossover$73,064$62,363.58$10,737$617.02+$62.3KNVIV
2$504,020$425,841.72$11,577$710.93+$492.4KNVIV
3$3,284,735$2,745,434.16$12,538$822.59+$3.27MNVIV
4$20,236,353$16,721,686.56$13,645$956.06+$20.22MNVIV
5$117,931,146$96,278,247.94$14,925$1,116.51+$117.92MNVIV
6$650,559,742$524,373,415.78$16,415$1,310.57+$650.54MNVIV
7$3,399,531,572$2,703,432,648.58$18,158$1,546.77+$3399.51MNVIV
8$16,840,226,624$13,202,727,840.99$20,213$1,836.20+$16840.21MNVIV
9$79,142,617,279$61,123,574,791.73$22,649$2,193.37+$79142.59MNVIV
10$353,147,458,701$268,464,858,212.91$25,558$2,637.42+$353147.43MNVIV

NVIV vs NNN: Complete Analysis 2026

NVIVStock

InVivo Therapeutics Holdings Corp., a research and clinical-stage biomaterials and biotechnology company, engages in developing and commercializing biopolymer scaffolding devices for the treatment of spinal cord injuries (SCI). It is developing a Neuro-Spinal Scaffold implant, which is an investigational bioresorbable polymer scaffold that is designed for implantation at the site of injury within a spinal cord to treat acute SCI. The company was incorporated in 2003 and is headquartered in Cambridge, Massachusetts.

Full NVIV Calculator →

NNNREIT

National Retail Properties invests primarily in high-quality retail properties subject generally to long-term, net leases. As of September 30, 2020, the company owned 3,114 properties in 48 states with a gross leasable area of approximately 32.4 million square feet and with a weighted average remaining lease term of 10.7 years.

Full NNN Calculator →
📬

Get this NVIV vs NNN comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

NVIV vs SCHDNVIV vs JEPINVIV vs ONVIV vs KONVIV vs MAINNVIV vs ADCNVIV vs EPRTNVIV vs FCPT

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.